Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma

Sharon J. Diskin, Mario Capasso, Robert W. Schnepp, Kristina A. Cole, Edward F. Attiyeh, Cuiping Hou, Maura Diamond, Erica L. Carpenter, Cynthia Winter, Hanna Lee, Jayanti Jagannathan, Valeria Latorre, Achille Iolascon, Hakon Hakonarson, Marcella Devoto, John M. Maris

Research output: Contribution to journalArticlepeer-review


Neuroblastoma is a cancer of the sympathetic nervous system that accounts for approximately 10% of all pediatric oncology deaths. Here, we report a genome-wide association study of 2,817 neuroblastoma cases and 7,473 controls. We identified two new associations at 6q16, the first within HACE1 (rs4336470; combined P = 2.7 × 10 -11; odds ratio 1.26, 95% confidence interval (CI) 1.18-1.35) and the second within LIN28B (rs17065417; combined P = 1.2 × 10 -8; odds ratio 1.38, 95% CI 1.23-1.54). Expression of LIN28B and let-7 miRNA correlated with rs17065417 genotype in neuroblastoma cell lines, and we observed significant growth inhibition upon depletion of LIN28B, specifically in neuroblastoma cells that were homozygous for the risk allele. Low HACE1 and high LIN28B expression in diagnostic primary neuroblastomas were associated with worse overall survival (P = 0.008 and 0.014, respectively). Taken together, these data show that common variants in HACE1 and LIN28B influence neuroblastoma susceptibility and indicate that both genes likely have a role in disease progression.

Original languageEnglish
Pages (from-to)1126-1130
Number of pages5
JournalNature Genetics
Issue number10
Publication statusPublished - Oct 2012

ASJC Scopus subject areas

  • Genetics


Dive into the research topics of 'Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma'. Together they form a unique fingerprint.

Cite this